Ramer Ladda syndrome

Active Research Protocols

  1. 10-C-0011 – Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014